Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus.
Ontology highlight
ABSTRACT: Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children, leading to significant morbidity and mortality worldwide. Despite its medical importance, no vaccine or effective therapeutic interventions are currently available. Therefore, there is a pressing need to identify novel antiviral drugs to combat RSV infections. Hsp90, a cellular protein-folding factor, has been shown to play an important role in the replication of numerous viruses. We here demonstrate that RSV requires Hsp90 for replication. Mechanistic studies reveal that inhibition of Hsp90 during RSV infection leads to the degradation of a viral protein similar in size to the RSV L protein, the viral RNA-dependent RNA polymerase, implicating it as an Hsp90 client protein. Accordingly, Hsp90 inhib
SUBMITTER: Geller R
PROVIDER: S-EPMC3584091 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA